FDA qualifies C-Path's Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C)

(Critical Path Institute (C-Path)) C-Path Patient-Reported Outcome Consortium announces the qualification of the Diary for Irritable Bowel Syndrome Symptoms-Constipation by FDA. The DIBSS-C was developed by the PRO Consortium's Irritable Bowel Syndrome Working Group to support symptom-based efficacy endpoints in clinical trials for products intended to treat constipation-predominant IBS in adults.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news